Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
41,278
-
Share change
-
-1,897
-
Total reported value
-
$140,000
-
Price per share
-
$3.36
-
Number of holders
-
5
-
Value change
-
-$14,614
-
Number of buys
-
2
-
Number of sells
-
3
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2015
As of 31 Dec 2015,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,278 shares.
The largest 5 holders included
VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, WELLS FARGO & COMPANY/MN, Creative Planning, and BlackRock Investment Management, LLC.
This page lists
5
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.